Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Walbrook receives Advanced Oncotherapy PR brief

Walbrook receives Advanced Oncotherapy PR brief

25th March 2014

Walbrook PR has received a communications brief to handle communications for Advanced Oncotherapy, a healthcare company listed on the AIM exchange.

The firm produces technologies responsible for the treatment of cancers globally and its systems are internationally-renowned.

Paul McManus, Walkbrook director, said: "We are delighted to have been appointed by Advanced Oncotherapy as a client at such an exciting period of change within the company."

In an effort to minimise damage to healthy tissue, Advanced Oncotherapy has recently focused its attentions on the development of new cost-effective and patient-friendly treatments.

The company recently announced its Linac Image Guided Hadron Technology therapy, which has been designed to significantly reduce the side-effects of invasive treatments.

Walbrook was awarded the brief following its strong work in the life sciences sector and its reputation for helping to boost growth for the businesses it works with. It is considered one of the leading financial PR agencies for healthcare companies.ADNFCR-8000103-ID-801706489-ADNFCR

We have hundreds of jobs available across the Healthcare industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips and straight to your inbox.